IDEXX Laboratories Misses on Q2 Earnings, Issues FY22 Guidance Below Consensus
IDEXX Laboratories Inc (NASDAQ:IDXX) reported Q2 revenues of $861 million, an increase of 4% Y/Y on a reported basis and…
Conformis Shares Jump On Personalized Orthopedic Implants Contract
Conformis Inc (NASDAQ:CFMS) entered into a multi-year agreement with Vizient Inc to offer personalized orthopedic implants to Vizient’s membership of healthcare facilities. The…
Zimmer Biomet Raises FY22 Outlook As Q2 Performance Exceeds Expectations
Zimmer Biomet Holdings Inc’s (NYSE:ZBH) Q2 sales increased by 1% Y/Y to $1.78 billion (up 6% on a constant currency basis),…
Nasdaq, S&P 500 Trading Lower Amid Pelosi’s Visit To Taiwan, Top Stories For August 2
Rising Tensions: Markets opened lower Tuesday morning, amid rising tensions between the United States and China. House Speaker Nancy Pelosi is set to visit Tawain Tuesday night, in a move that has upset Chinese officials.
DuPont Revises Annual Guidance, Trails Wall Street Estimates, Shares Tick Lower
DuPont de Nemours Inc (NYSE: DD) Q2 sales increased 7% Y/Y to $3.3 billion, missing the consensus of $4.2 billion.
‘OPEC+ sees slightly smaller oil market surplus this year, sources say’ -Reuters
https://www.reuters.com/business/energy/opec-sees-slightly-smaller-oil-market-surplus-this-year-sources-say-2022-08-02/
OPEC+ sees this year's oil market as slightly less supplied than previously thought, a day
Clarus Shares Gain Post Q2 Results
Clarus Corp (NASDAQ:CLAR) reported second-quarter FY22 sales growth of 57% year-on-year to $114.93 million, beating the consensus of $110.16 million. Domestic…
Indian Food-Delivery Firm Zomato To Appoint Multiple CEOs: Bloomberg
Indian food-delivery company Zomato Ltd will appoint multiple CEOs to lead its business units, Bloomberg reported. The company is also planning…
SEC Charges 11 People In $300M Crypto Ponzi Scheme
The Securities and Exchange Commission has charged 11 people for their roles in creating and promoting an allegedly fraudulent crypto-focused…
AbbVie, Sosei Build In 2020 Pact With New Neurological Disease-Focused Agreement
Sosei Group Corporation and AbbVie Inc (NYSE:ABBV) announced a new drug discovery collaboration and option-to-license agreement to discover, develop and commercialize small molecules…